SHANDEL DOUGLAS: Open Payments
NPI 1649798455 · RIVER EDGE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$312 in 18 payments from 4 companies in 2025. Trend: 2023 $17 · 2024 $231 · 2025 $312
Food & beverage: $312
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $165 |
| Otsuka America Pharmaceutical, Inc. | 5 | $99 |
| Almatica Pharma LLC | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: VRAYLAR, REXULTI, LOREEV XR, ABILIFY MAINTENA, CAPLYTA.
Industry payments across NJ — which companies pay providers there.
